DOI: 10.3724/SP.J.1264.2011.00017

Chinese Journal of Multiple Organ Diseases in the Elderly (中华老年多器官疾病杂志) 2011/10:4 PP.353-356

PAI-1 mRNA expression and myocardial mircovascular change in diabetic rats

Objective To evaluate whether hyperglycemia and ageing influence myocardial microvessels and the expression of myocardial PAI-1 mRNA by observing changes in the number of myocardial microvessels and the expression of myocardial PAI-1 mRNA in aged and young diabetic rats. Methods Aged and young SD rats were randomized to diabetes mellitus (DM) group and control group. The DM model was established by intraperitoneal STZ injection. The rats were raised for 8 weeks and sacrificed. Part of the left ventricular tissue was used for immunohistochemical evaluation, and the remaining part was used for detection of PAI-1 mRNA exprerssion. Myocardial microvascular endothelial specific antigen CD34 was detected by using CD34 antibody and EnVision immunohistochemistry. The number of myocardial microvessels was counted by Medical Image Analysis Software. The expression of myocardial PAI-1 mRNA was detected by real-time fluorescence quantitative PCR. Results The number of myocardial microvessels of DM group was significantly smaller than that of the control in all age groups 8 weeks after modeling (P<0.01=, and the number of myocardial microvessels of the aged DM group was significantly smaller than that of the young DM group and young control group (P<0.01=, while there was no significant difference between the aged and young control groups (P>0.05). The expression of myocardial PAI-1 mRNA in DM rats of all age groups was significantly increased as compared with the control group at corresponding ages (P<0.01=. In addition, the expression of myocardial PAI-1 mRNA in the aged control rats was higher than that in the young control rats (P<0.05). Conclusion Ageing has a significant influence on the number of myocardial microvessels in diabetic rats but not in non-diabetic rats. Ageing enhances the expression of myocardial AI-1 mRNA in rats. The number of myocardial microvessels is decreased and the expression of myocardial PAI-1 mRNA is enhanced in diabetic rats at all ages.

Key words:diabetes mellitus,myocardium,number, microvessel,plasminogen activator inhibitor,age reporting

ReleaseDate:2014-07-21 15:56:24

[1] Carr ME. Diabetes mellitus: a hypercoagulable state[J]. J Diabetes Complications, 2001, 15(1): 44-54.

[2] 郭 鹞, 任东青. 微循环学基础与实验方法[M]. 西安: 第四军医大学出版社, 2005: 123-124.

[3] Wiman B, Coollen D. Purificial and characterization of human antiplasmin, the fastacting plasmin inhibitor in plasm[J]. Eur J Biochem, 1977, 78(1): 19-26.

[4] Eddy AA, Fogo AB. Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action[J]. J Am Soc Nephrol, 2006, 17(11): 2999-3012.

[5] Liu RM. Oxidative stress, plasmingeon activator inhibtor 1, and lung fibrosis[J]. Antioxid Redax Signal, 2008, 10(2): 303-319.

[6] Hoffstedt J,Persson L,Isaksson B, et al. The common-675 4G/5G polymorphism in the plasmingeon activator inhibitor-1 gene is strongly associated with obesity[J]. Diabetologia, 2002, 45(4): 584-587.

[7] Eva A, Marcus L, Tom O, et al. uPA and PAI-1 in rectal cancer: relationship to radiotherapy and clinical outcome[J]. J Surg Res, 2009, 153(1): 46-53.

[8] Festa A, D’Agostino RJr, Tracy RP, et al. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study[J]. Diabetes, 2002, 51(4): 1131-1137.

[9] Kitagawa N,Yano Y,Gabazza EC, et al. Different metabolic correlations of thrombin activatable fibrinolysis inhibitor-1 in non-obese type 2 diabetic patients[J]. Diabetes Res Clin Pract, 2006, 73(2): 150-157.

[10] Laima B, Kevin R, Alicia J, et al. Plasminogen activator inhibitor-1 activity in type 2 diabtetes: a different relationship with coronary heart disease and diabetic retinopathy[J]. Arterioscler Thromb Vasc Biol, 2008, 28(4): 786-791.

[11] Paueksakon P, Revelo MP, Ma LJ, et al. Microangiopathic injury and augmented PAI-1 in humain diabetic nephropathy[J]. Kidney Int, 2002, 61(6): 2142-2148.

[12] Grant MB, Spoerri PE, Player DW, et al. Plasminogen activator inhibitor(PAI)-1 overexpression in retinal microvessels of PAI-1 transgenic mice[J]. IOVS, 2000, 41(8): 2296-2302.

[13] Javorshil S, Richard-Harston S, Labrouchel G. Relative influence of age and thromotic history on hemostatic parameters[J]. Thromb Res, 1998, 91(5): 241-248.